Horizon 2020
The EU Framework Programme for Research and Innovation
The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.
Dr. Tiacci, University of Perugia, © E. Tiacci
